Onconetix Historical Cash Flow
| ONCO Stock | USD 0.56 0.05 8.20% |
Analysis of Onconetix cash flow over time is an excellent tool to project Onconetix future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Non Cash Items of 26.4 M or Capital Expenditures of 66.5 K as it is a great indicator of Onconetix ability to facilitate future growth, repay debt on time or pay out dividends.
Onconetix |
About Onconetix Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Onconetix balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Onconetix's non-liquid assets can be easily converted into cash.
Onconetix Cash Flow Chart
Add Fundamental
Capital Expenditures
Capital Expenditures are funds used by Onconetix to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Onconetix operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Onconetix financial statement analysis. It represents the amount of money remaining after all of Onconetix operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Change To Inventory
The increase or decrease in the amount of inventory a company has over a certain period.Most accounts from Onconetix's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Onconetix current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Onconetix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Onconetix Stock, please use our How to Invest in Onconetix guide.At this time, Onconetix's Other Cashflows From Financing Activities is very stable compared to the past year. As of the 31st of January 2025, Depreciation is likely to grow to about 53.1 K, though Change In Cash is likely to grow to (18.1 M).
Onconetix cash flow statement Correlations
Click cells to compare fundamentals
Onconetix Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Onconetix cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | (1.7M) | (2.4M) | 23.8M | (21.2M) | (19.1M) | (18.1M) | |
| Free Cash Flow | (1.7M) | (2.0M) | (8.7M) | (13.6M) | (12.3M) | (11.7M) | |
| Change In Working Capital | (468.6K) | 1.2M | 2.5M | 1.6M | 1.9M | 1.1M | |
| Other Cashflows From Financing Activities | (11.8K) | (334.2K) | (1.8M) | 2.1M | 2.4M | 2.5M | |
| Depreciation | 3.1K | 4.9K | 6.8K | 43.9K | 50.5K | 53.1K | |
| Other Non Cash Items | 292.1K | 23.4K | 263.9K | 21.8M | 25.1M | 26.4M | |
| Capital Expenditures | 11.8K | 1.9K | 9.3K | 55.0K | 63.3K | 66.5K | |
| Total Cash From Operating Activities | (1.7M) | (2.0M) | (8.7M) | (13.6M) | (12.2M) | (11.6M) | |
| Change To Account Receivables | (1.5K) | (115.0K) | (23.3K) | (62.3K) | (56.1K) | (58.9K) | |
| Net Income | (1.6M) | (3.4M) | (13.4M) | (37.4M) | (33.7M) | (32.0M) | |
| Total Cash From Financing Activities | 0.0 | (334.2K) | 32.5M | 1.0M | 1.2M | 1.1M | |
| End Period Cash Flow | 4.3M | 1.9M | 25.8M | 4.6M | 5.2M | 9.4M |
Pair Trading with Onconetix
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Onconetix position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Onconetix will appreciate offsetting losses from the drop in the long position's value.Moving together with Onconetix Stock
Moving against Onconetix Stock
| 0.68 | BMY | Bristol Myers Squibb Earnings Call This Week | PairCorr |
| 0.53 | MLAB | Mesa Laboratories Earnings Call This Week | PairCorr |
| 0.48 | MDGL | Madrigal Pharmaceuticals | PairCorr |
| 0.41 | GILD | Gilead Sciences Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Onconetix could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Onconetix when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Onconetix - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Onconetix to buy it.
The correlation of Onconetix is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Onconetix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Onconetix moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Onconetix can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Onconetix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Onconetix Stock, please use our How to Invest in Onconetix guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Onconetix. If investors know Onconetix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Onconetix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Onconetix is measured differently than its book value, which is the value of Onconetix that is recorded on the company's balance sheet. Investors also form their own opinion of Onconetix's value that differs from its market value or its book value, called intrinsic value, which is Onconetix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Onconetix's market value can be influenced by many factors that don't directly affect Onconetix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Onconetix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Onconetix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Onconetix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.